These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
234 related articles for article (PubMed ID: 30696372)
21. Most important barriers and facilitators of HTA usage in decision-making in Europe. Cheung KL; Evers SMAA; De Vries H; Levy P; Pokhrel S; Jones T; Danner M; Wentlandt J; Knufinke L; Mayer S; Hiligsmann M Expert Rev Pharmacoecon Outcomes Res; 2018 Jun; 18(3):297-304. PubMed ID: 29303374 [TBL] [Abstract][Full Text] [Related]
22. [European Collaboration in Medical Device Assessment: One Step Towards Cross-Border Health Care]. Mayer J; Ettinger S; Nachtnebel A Gesundheitswesen; 2018 Mar; 80(3):210-216. PubMed ID: 28628932 [TBL] [Abstract][Full Text] [Related]
23. MOST IMPORTANT BARRIERS AND FACILITATORS REGARDING THE USE OF HEALTH TECHNOLOGY ASSESSMENT. Cheung KL; Evers SMAA; de Vries H; Hiligsmann M Int J Technol Assess Health Care; 2017 Jan; 33(2):183-191. PubMed ID: 28849758 [TBL] [Abstract][Full Text] [Related]
24. Co-ordinating health technology assessment in Canada: a European perspective. McDaid D Health Policy; 2003 Feb; 63(2):205-13. PubMed ID: 12543533 [TBL] [Abstract][Full Text] [Related]
25. Recommendations to overcome barriers to the use of artificial intelligence-driven evidence in health technology assessment. Zemplényi A; Tachkov K; Balkanyi L; Németh B; Petykó ZI; Petrova G; Czech M; Dawoud D; Goettsch W; Gutierrez Ibarluzea I; Hren R; Knies S; Lorenzovici L; Maravic Z; Piniazhko O; Savova A; Manova M; Tesar T; Zerovnik S; Kaló Z Front Public Health; 2023; 11():1088121. PubMed ID: 37181704 [TBL] [Abstract][Full Text] [Related]
26. Introduction: health technology assessment and the European Union. Banta D; Oortwijn W Int J Technol Assess Health Care; 2000; 16(2):299-302. PubMed ID: 10932410 [TBL] [Abstract][Full Text] [Related]
27. Who's afraid of institutionalizing health technology assessment (HTA)?: Interests and policy positions on HTA in the Czech Republic. Löblová O Health Econ Policy Law; 2018 Apr; 13(2):137-161. PubMed ID: 29108525 [TBL] [Abstract][Full Text] [Related]
28. Stakeholder perspectives on cooperation in the clinical and nonclinical health technology assessment domains. Zimmermann G; Michelmore S; Hiligsmann M Int J Technol Assess Health Care; 2023 May; 39(1):e29. PubMed ID: 37212049 [TBL] [Abstract][Full Text] [Related]
29. The impact of the treaty basis on health policy legislation in the European Union: a case study on the tobacco advertising directive. Boessen S; Maarse H BMC Health Serv Res; 2008 Apr; 8():77. PubMed ID: 18397520 [TBL] [Abstract][Full Text] [Related]
30. [Quality of health care, accreditation, and health technology assessment in Croatia: role of agency for quality and accreditation in health]. Mittermayer R; Huić M; Mestrović J Acta Med Croatica; 2010 Dec; 64(5):425-34. PubMed ID: 21692267 [TBL] [Abstract][Full Text] [Related]
31. Best-worst scaling to assess the most important barriers and facilitators for the use of health technology assessment in Austria. Feig C; Cheung KL; Hiligsmann M; Evers SMAA; Simon J; Mayer S Expert Rev Pharmacoecon Outcomes Res; 2018 Apr; 18(2):223-232. PubMed ID: 28862060 [TBL] [Abstract][Full Text] [Related]
32. Health technology assessment and health care in the European Union. Banta D; Oortwijn W Int J Technol Assess Health Care; 2000; 16(2):626-35. PubMed ID: 10932427 [TBL] [Abstract][Full Text] [Related]
33. Hospital-based health technology assessment (HTA) in Finland: a case study on collaboration between hospitals and the national HTA unit. Halmesmäki E; Pasternack I; Roine R Health Res Policy Syst; 2016 Apr; 14():25. PubMed ID: 27044400 [TBL] [Abstract][Full Text] [Related]
34. Development of health technology assessment in China: New challenges. Chen Y; He Y; Chi X; Wei Y; Shi L Biosci Trends; 2018; 12(2):102-108. PubMed ID: 29760354 [TBL] [Abstract][Full Text] [Related]
35. European Collaboration in Health Technology Assessment (HTA): goals, methods and outcomes with specific focus on medical devices. Erdös J; Ettinger S; Mayer-Ferbas J; de Villiers C; Wild C Wien Med Wochenschr; 2019 Sep; 169(11-12):284-292. PubMed ID: 30725440 [TBL] [Abstract][Full Text] [Related]
36. The fourth edition of the European Network for Health Technology Assessment Forum: highlights and outcomes. Tafuri G; Bélorgey C; Favaretti C; Frénoy E; Giorgio F; Guardian M; Hebborn A; Houÿez F; Imbert J; Lacombe D; Garcia JL; Garrett Z; Petelos E; Saeterdal I; Schuurman A; Skjöldebrand AL; Strammiello V; Widmer D; Willemsen A; Hedberg N Int J Technol Assess Health Care; 2020 Jun; 36(3):191-196. PubMed ID: 32317039 [TBL] [Abstract][Full Text] [Related]
37. An EU-wide approach to HTA: An irrelevant development or an opportunity not to be missed? Kanavos P; Angelis A; Drummond M Eur J Health Econ; 2019 Apr; 20(3):329-332. PubMed ID: 30868380 [TBL] [Abstract][Full Text] [Related]
38. Harmonization of HTA--based reimbursement and regulatory approval activities: a qualitative study. Tsoi B; O'Reilly D; Masucci L; Drummond M; Goeree R J Popul Ther Clin Pharmacol; 2015; 22(1):e78-89. PubMed ID: 25715384 [TBL] [Abstract][Full Text] [Related]
39. Implementing the EU HTA regulation: Insights from semi-structured interviews on patient expectations, Belgian and European institutional perspectives, and industry outlooks. Desmet T; Brijs M; Vanderdonck F; Tops S; Simoens S; Huys I Front Pharmacol; 2024; 15():1369508. PubMed ID: 38659588 [No Abstract] [Full Text] [Related]
40. HEALTH TECHNOLOGY ASSESSMENT IN CENTRAL-EASTERN AND SOUTH EUROPE COUNTRIES: BOSNIA AND HERZEGOVINA. Guzvic V; Catic T; Kostic M Int J Technol Assess Health Care; 2017 Jan; 33(3):390-395. PubMed ID: 28434417 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]